Prof. Dr. Emrah Can | Medicine and Health Sciences | Best Researcher Award

Prof. Dr. Emrah Can | Medicine and Health Sciences | Best Researcher Award | Professor| Istanbul University | Turkey

Prof. Dr. Emrah Can is a highly accomplished pediatrician and neonatology-focused clinician-scientist recognized for his extensive contributions to neonatal health, pediatric infectious diseases, neonatal sepsis, retinopathy of prematurity, and pediatric critical care. Prof. Dr. Emrah Can completed his medical training at Istanbul University Faculty of Medicine, followed by his medical specialization in Child Health and Diseases at Health Sciences University, İstanbul Bağcılar Training and Research Hospital, where he developed strong clinical expertise in neonatal nutrition, early sepsis biomarkers, high-risk neonatal monitoring, and pediatric intensive care. He progressed academically to the ranks of Associate Professor and Professor through consistent research productivity, clinical excellence, and mentorship. Throughout his career, Prof. Dr. Emrah Can has supervised numerous pediatric specialization theses focused on neonatal sepsis biomarkers, MRSA carriage among hospitalized children, melatonin levels in early sepsis, prognostic tools for pediatric traumatic brain injury, differentiation of lower respiratory tract infection and colonization in tracheostomized children, fetal malnutrition indicators, and hyperbilirubinemia-related risk factors, demonstrating his commitment to developing evidence-based pediatric protocols and training the next generation of pediatric specialists. His research interests include neonatal immunology, inflammation markers, nutritional interventions for premature infants, oxygen affinity biomarkers, neonatal thrombosis, and innovative hypothesis-driven models for predicting neonatal morbidity. His research skills include statistical analysis, advanced clinical data interpretation, hypothesis modeling, neonatal diagnostic model development, and interdisciplinary collaboration. Prof. Dr. Emrah Can has authored impactful publications in reputable journals such as Medical Hypotheses, International Ophthalmology, European Journal of Pediatrics, Pediatric Cardiology, and Journal of Paediatrics and Child Health, contributing significantly to early detection strategies for NEC, ROP, neonatal thrombosis, and hematologic alterations in neonates. His scientific memberships reflect his professional commitment, including active participation in the Pediatric Allergy and Asthma Academy Association, Turkish National Pediatric Association, Child Friends Association, and Turkish Neonatology Association. He has also served in academic administrative roles, including program head positions that highlight his leadership in medical education. Prof. Dr. Emrah Can has received recognition for his academic achievements, research contributions, and involvement in pediatric healthcare improvement initiatives. Overall, Prof. Dr. Emrah Can demonstrates exceptional clinical acumen, research innovation, collaborative engagement, and leadership in pediatric and neonatal medicine, positioning him as a scholar whose contributions continue to shape evidence-based neonatal care, advance scientific understanding of pediatric diseases, and improve health outcomes for vulnerable newborn populations.

Profile:  scopus | ORCID

Featured Publications

1. Can, E. (2025). Development of a scoring model integrating inflammatory markers for predicting ROP in preterm neonates. International Ophthalmology.

2. Can, E. (2025). Postnatal hemoglobin P50 as a surrogate marker for hypoxia-driven NEC in preterm infants: A mechanistic hypothesis. Medical Hypotheses.

3. Can, E. (2025). Phototherapy modifies hematologic markers without inducing inflammation in neonates: A retrospective observational study. European Journal of Pediatrics.

4. Can, E. (2025). Could parabiotics safely enhance immune maturation and mitigate NEC/sepsis in preterm neonates? Medical Hypotheses.

5. Can, E. (2025). Early haemoglobin oxygen affinity as a hypothesis-generating marker for retinopathy of prematurity risk in preterm infants. Journal of Paediatrics and Child Health.

6. Can, E. (2025). Neonatal portal vein thrombosis: A case series from a tertiary NICU. Pediatric Cardiology.